General Info

KineMed was founded in 1999 to provide kinetic solutions to problems in disease management and drug development. The company provides tests that measure molecular kinetics in living systems, which include humans. KineMed offers patented technology that is based on the combination of sensitive mass spectrometry and the labeling of molecular pathways with non-radioactive tracers in vivo. The company can measure the ability of a drug to intervene in a disease process, as well as follow metabolic events in the pathways of disease and health. KineMed s assays are applicable at every level of the drug development and drug approval process, as well as in medical diagnostic and therapeutic applications. KineMed maintains its headquarters in Emeryville, Calif.